Royal Bank of Canada’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-34,774
| Closed | -$656K | – | 6564 |
|
|
2019
Q3 | $656K | Sell |
34,774
-28,921
| -45% | -$546K | ﹤0.01% | 3139 |
|
|
2019
Q2 | $749K | Sell |
63,695
-2,810
| -4% | -$33K | ﹤0.01% | 3058 |
|
|
2019
Q1 | $908K | Buy |
66,505
+1,773
| +3% | +$24.2K | ﹤0.01% | 2787 |
|
|
2018
Q4 | $663K | Buy |
64,732
+18,950
| +41% | +$194K | ﹤0.01% | 2944 |
|
|
2018
Q3 | $762K | Buy |
45,782
+7,847
| +21% | +$131K | ﹤0.01% | 3052 |
|
|
2018
Q2 | $598K | Sell |
37,935
-18,875
| -33% | -$298K | ﹤0.01% | 3127 |
|
|
2018
Q1 | $721K | Buy |
56,810
+23,121
| +69% | +$293K | ﹤0.01% | 2875 |
|
|
2017
Q4 | $386K | Buy |
33,689
+24,614
| +271% | +$282K | ﹤0.01% | 3295 |
|
|
2017
Q3 | $111K | Buy |
9,075
+6,649
| +274% | +$81.3K | ﹤0.01% | 4230 |
|
|
2017
Q2 | $28K | Sell |
2,426
-187,827
| -99% | -$2.17M | ﹤0.01% | 4679 |
|
|
2017
Q1 | $3.96M | Sell |
190,253
-16,644
| -8% | -$346K | ﹤0.01% | 1714 |
|
|
2016
Q4 | $4.3M | Buy |
206,897
+10,563
| +5% | +$220K | ﹤0.01% | 1647 |
|
|
2016
Q3 | $6.43M | Buy |
196,334
+25,980
| +15% | +$851K | ﹤0.01% | 1423 |
|
|
2016
Q2 | $4.25M | Buy |
+170,354
| New | +$4.25M | ﹤0.01% | 1630 |
|
|
2016
Q1 | – | Sell |
-107
| Closed | -$3K | – | 5908 |
|
|
2015
Q4 | $3K | Sell |
107
-1,356
| -93% | -$38K | ﹤0.01% | 5534 |
|
|
2015
Q3 | $48K | Sell |
1,463
-2,316
| -61% | -$76K | ﹤0.01% | 4571 |
|
|
2015
Q2 | $200K | Sell |
3,779
-4,353
| -54% | -$230K | ﹤0.01% | 3893 |
|
|
2015
Q1 | $234K | Sell |
8,132
-6,913
| -46% | -$199K | ﹤0.01% | 3683 |
|
|
2014
Q4 | $438K | Sell |
15,045
-5,277
| -26% | -$154K | ﹤0.01% | 3177 |
|
|
2014
Q3 | $258K | Buy |
20,322
+1,794
| +10% | +$22.8K | ﹤0.01% | 3486 |
|
|
2014
Q2 | $372K | Buy |
+18,528
| New | +$372K | ﹤0.01% | 3223 |
|